Intervention Review

You have free access to this content

Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer

  1. Theresa A Lawrie1,
  2. Andrew Bryant2,
  3. Alison Cameron3,*,
  4. Emma Gray4,
  5. Jo Morrison5

Editorial Group: Cochrane Gynaecological Cancer Group

Published Online: 9 JUL 2013

Assessed as up-to-date: 2 JUL 2013

DOI: 10.1002/14651858.CD006910.pub2


How to Cite

Lawrie TA, Bryant A, Cameron A, Gray E, Morrison J. Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer. Cochrane Database of Systematic Reviews 2013, Issue 7. Art. No.: CD006910. DOI: 10.1002/14651858.CD006910.pub2.

Author Information

  1. 1

    Royal United Hospital, Cochrane Gynaecological Cancer Group, Bath, UK

  2. 2

    Newcastle University, Institute of Health & Society, Newcastle upon Tyne, UK

  3. 3

    University Hospitals Bristol NHS Foundation Trust, Department of Clinical Oncology, Bristol, UK

  4. 4

    Musgrove Park Hospital, The Beacon Centre, Taunton, Somerset, UK

  5. 5

    Musgrove Park Hospital, Department of Obstetrics and Gynaecology, Taunton, Somerset, UK

*Alison Cameron, Department of Clinical Oncology, University Hospitals Bristol NHS Foundation Trust, Bristol Haematology and Oncology Centre, Horfield Road, Bristol, BS2 8ED, UK. Alison.Cameron@UHBristol.nhs.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 9 JUL 2013

SEARCH

  1. You have free access to this content

    Current Version

    Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer

    Theresa A Lawrie, Andrew Bryant, Alison Cameron, Emma Gray and Jo Morrison

    Article first published online: 9 JUL 2013 | DOI: 10.1002/14651858.CD006910.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Pegylated liposomal doxorubicin for relapsed ovarian cancer

    Alison Cameron, Emma Gray and Chris Williams

    Article first published online: 23 JAN 2008 | DOI: 10.1002/14651858.CD006910